Generic Prescription Drug Settlements: Here’s Who’s Eligible for Cash
October 1, 2026 Attorneys general settlements resolve litigation that alleged major prescription drug makers agreed to fix prices for over 100 generics sold nationwide.
Lawsuit Filings
Lawsuit: Merck, Glenmark, Par Unlawfully Suppressed Competition for Zetia, Generic Alternative
April 5, 2018 A group of pharmaceutical companies is facing a lawsuit alleging the defendants entered into an unlawful antitrust agreement that allowed them to reap significant profits from the sales of Zetia and its generic by delaying market competition.
Merck, Glenmark Accused of Delaying Generic Alternatives to Zetia
February 6, 2018 Merck & Co., Inc., Glenmark Pharmaceuticals, Ltd., and several of their respective subsidiaries are facing a lawsuit that claims the parties unlawfully delayed the launch of generic alternatives to Merck’s brand name high cholesterol drug, Zetia.